2003 - The Year of BBG

I happen to have a shitload of thse at 2.5p because I watch the charts and the sector.

but you bunch of old women put me right off.

news/ analysis/ prospects.

or just the same old bollox from rampers.


for starters.

appears to be double bottoming.

yes nice cash per share, and tax write off if acquired etc, and liquid assets ( but frankly it had the same story when it was 30p).

fundamentally, will any of its products work before it runs out of cash.

come on you clueless rampers do some research.

every other biotech company is in a similar tax write off situation, and are overvalued, so why is this good.

I am extremely long at 2.5p but lets have some research and insight you lzy feckers.

there are reasons this is a buy. please elucidate for everyone ( I'm not telling you)


ape